FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4832011000001103: Palivizumab 50mg powder and solvent for solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21390501000001112 Palivizumab 50mg powder and solvent for solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21390601000001111 Palivizumab 50mg powder and solvent for solution for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Is pack of Palivizumab 50mg powder and solvent for injection solution vial false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has active ingredient Palivizumab false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has VMP Palivizumab 50mg powder and solvent for injection solution vial false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has specific active ingredient Palivizumab true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has VMP Palivizumab 50mg powder and solvent for solution for injection vials false Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has VMP Palivizumab 50mg powder and solvent for solution for injection vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) 1 vial Is a True Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start